First experience of SARS-CoV-2 infections in solid organ transplant recipients in the Swiss Transplant Cohort Study
Jonathan Tschopp(University of Lausanne), Christian van Delden, Dionysios Neofytos(Johns Hopkins University), Hans H. Hirsch(University of Basel), Arnaud G. L’Huillier, Christian Garzoni(Clinica Luganese Moncucco), Macé M. Schuurmans(University Hospital of Zurich), Oriol Manuel(University of Lausanne), Matthaios Papadimitriou‐Olivgeris(University Hospital of Lausanne), Manuel Pascual(University of Lausanne), Nina Khanna(University Hospital of Basel), Thierry Berney(University of Geneva), Thomas Müller(University Hospital of Zurich), Jürg Steiger, Matteo Mombelli(University of Lausanne), Dario Meloni(Clinica Luganese Moncucco), Nicolas J. Mueller(University Hospital of Zurich)
Cited by 134
Related Papers
Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity
|Cell|2021|656
Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study
|Clinical Infectious Diseases|2012|299
Cytomegalovirus in transplantation – challenging the<i>status quo</i>
|Clinical Transplantation|2006|288